Press release
Pulmonary Drug Delivery Devices Market Size will Grow Profitably in the Near Future
Obtain Report Details @ https://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html
Increasing Patient Base to Boost Global Pulmonary Drug Delivery Systems Market
According to the World Health Organization, around 300 million people across the globe suffer from asthma. Growing patient pool affected with respiratory diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) is one of the prime factors set to contribute to the global pulmonary drug delivery systems market.
Rapid absorption of different macromolecules and most of the therapeutic drugs over the alveolar epithelium of the distal lung has allowed pulmonary drug delivery systems to become efficacious. Technical advances in pulmonary drug delivery systems as well as drug formulations are expected to propel the overall market in the near future. Presently, the therapeutic applications of pulmonary drug delivery are expanding and this will help the market’s growth prospects.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=873
However, patent expiry of drug delivery systems and delay in obtaining approvals from regulatory authorities are expected to negatively affect the global pulmonary drug delivery systems market. During the next couple of years, developing economies will present immense market potential for pulmonary drug delivery systems, owing to the growing patient base.
Nebulizers to be Fastest Growing Segment of Global Pulmonary Drug Delivery Systems Market
On the basis of product type, the global pulmonary drug delivery systems market has been segmented into nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs). In 2012, the overall market was dominated by metered dose inhalers, which accounted for 56.8% of the market. Dry powder inhalers were the second largest segment in the market the same year. During the period between 2013 and 2019, nebulizers are expected to be the fastest growing segment of the pulmonary drug delivery systems market. In terms of application, the global pulmonary drug delivery systems market has been categorized into cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). In the coming years, the usage of pulmonary drug delivery systems for the treatment of asthma and COPD is expected to increase considerably.
Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=873
North America Led Global Pulmonary Drug Delivery Systems Market in 2012
Globally, the pulmonary drug delivery systems market has been divided into four key regions: Europe, Asia Pacific, North America, and Rest of the World. In 2012, North America was the leading market for pulmonary drug delivery systems, owing to the increasing patient base and robust healthcare infrastructure. During the period between 2013 and 2019, Asia Pacific is expected to contribute significantly to the growth of the market due to the growing number of people smoking tobacco. Some of the key players in the global pulmonary drug delivery systems market are CareFusion Corporation, 3M Health Care, Novartis AG, Omron Healthcare Inc., and GlaxoSmithKline.
Popular Research Reports by TMR –
Post-operative Nausea and Vomiting Market: http://markets.businessinsider.com/news/stocks/post-operative-nausea-and-vomiting-market-to-become-worth-us-3-100-mn-by-2026-says-tmr-1027343575
Sterilization Wrap Market: http://www.prnewswire.co.uk/news-releases/sterilization-equipment-market-to-gain-us-846553-mn-by-2026-says-tmr-687864421.html
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Drug Delivery Devices Market Size will Grow Profitably in the Near Future here
News-ID: 1213874 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
